Longevity Biotech Company
Longevity Biotech, a Philadelphia, PA-based developer of a new class of therapeutics via artificial protein technology. Longevity Biotech focuses on pharmaceutical preparation. Its hybridtides are targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymesand tunable to very stable molecular structures.
Total Funding:
$836.4K
Headquarters:
United States
Employee Number:
1-10
Estimated Revenue:
Less than $1M
Last Funding Type:
Grant
Number Of Exists:
Grant
Technology:
Metabolic Disorders
Investor Type:
Company
Investors Number:
2
Founded Date:
2010
Industry:
Energetic Process